Cover Page
The following handle holds various files of this Leiden University dissertation:
http://hdl.handle.net/1887/79947
Author: He, J.
Uncovering vulnerabilities in
triple-negative breast cancer
PhD thesis with summary in Dutch
Uncovering vulnerabilities in triple-negative breast cancer
Jichao He @October 2019
The research described in this thesis was performed at the division Drug Discovery
and Safety of Leiden Academic Centre for Drug Research (LACDR), Leiden
University (Leiden, The Netherlands).
The research was financially supported by China Scholarship Council (no.
201407060007) and the European Research Council Advanced grant Triple-BC
(grant no. 322737).
Cover by: Adapted from
www.besthdwallpaper.com/hua-hui/yi-zhu-pu-gong-ying-hua-dt_zh-CN-11102 (under CC0 license) by Jichao He with no intention of
infringing copyright
Thesis lay-out by Jichao He
Printed by Ridderprint | www.ridderprint.nl
Uncovering vulnerabilities in
triple-negative breast cancer
Proefschrift
Ter verkrijging van de graad van Doctor aan de Universiteit Leiden,
op gezag van Rector Magnificus prof. mr. C.J.J.M. Stolker,
volgens besluit van het College voor Promoties
te verdedigen op donderdag 31 oktober 2019
klokke 10:00 uur
door
Jichao He
Promotor
Prof. Dr. B. van de Water
Co-promotor
Dr. Y. Zhang
Promotiecommissie
Prof. Dr. H. Irth (Chair)
Prof. Dr. J.A. Bouwstra (Secretary)
Table of Contents
Chapter 1 ... 1
General introduction and scope of the thesis Chapter 2 ... 19
FRET biosensor-based kinase inhibitor screen for ERK and AKT activity reveals differential kinase dependencies for proliferation in TNBC cells Chapter 3 ... 39
A kinome screen for lapatinib drug resistance identifies FYN as a suppressor of EGFR/PI3K/AKT signaling axis dependency in triple-negative breast cancer Chapter 4 ... 57
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer Chapter 5 ... 79
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression Chapter 6 ... 105